Sensex

Nifty

USDINR

GBPINR

EURINR

Thursday, 01 January 2026 01:59 AM	Asian-Paints2766.40	Hind-Unilever2312.20	ITC366.95	Trent4282.90	Larsen-and-Toubro4136.10	M-and-M3760.05	Reliance-Industr1579.30	Tata-Steel181.00	Titan-Company4061.90	SBI986.45	Bharat-Electron395.55	Kotak-Mah-Bank2210.50	Infosys1635.60	Bajaj-Finance975.00	Sun-PharmaInds1718.85	HDFC-Bank991.95	TCS3223.95	ICICI-Bank1340.20	Power-Grid-Corpn266.30	Maruti-Suzuki16732.35	Axis-Bank1278.85	HCL-Technologies1643.00	NTPC335.80	Bharti-Airtel2119.05	Tech-Mahindra1606.90	Adani-Ports1482.90	UltraTech-Cem11865.80	Bajaj-Finserv2034.25	Interglobe-Aviat5118.95	Eternal283.85
15 mins delay SENSEX 85,291.03 [70.43]	-3.25 -0.12%	-3.10 -0.13%	-36.05 -8.95%	4.85 0.11%	53.00 1.30%	50.45 1.36%	9.90 0.63%	0.95 0.53%	11.25 0.28%	4.25 0.43%	-4.15 -1.04%	9.75 0.44%	19.15 1.18%	-11.65 -1.18%	-0.90 -0.05%	0.20 0.02%	18.20 0.57%	-2.70 -0.20%	1.75 0.66%	28.10 0.17%	10.15 0.80%	18.65 1.15%	6.35 1.93%	13.35 0.63%	15.50 0.97%	13.40 0.91%	80.35 0.68%	-4.55 -0.22%	58.60 1.16%	5.90 2.12%

Hot Pursuit

Scrips, which has significant changes during the market hours.

Dr Reddy's Swiss subsidiary gets USFDA CRL for biosimilar AVT03

01-Jan-26 11:57Hrs IST

AVT03 is a proposed biosimilar to Amgen's Prolia and Xgeva and has been developed by Alvotech hf. According to the company, the CRL pertains to observations made by the US Food and Drug Administration (USFDA) during a pre-licence inspection of Alvotech's manufacturing facility in Reykjavik, Iceland.

Hyderabad-based Dr. Reddy's Laboratories is a global pharmaceutical company. It offers a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC.

The company's consolidated net profit jumped 7.3% to Rs 1,347.10 crore on a 9.8% increase in revenue from operations to Rs 8,804.90 crore in Q2 FY26 over Q2 FY25.

The counter slipped 1.66% to Rs 1,250 on the BSE.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

A Muthoot M George Enterprise